Skip to main content
Clinical Trials/NCT06306924
NCT06306924
Recruiting
Not Applicable

UNC Metastatic Cancer Radiation Therapy Registry

UNC Lineberger Comprehensive Cancer Center1 site in 1 country2,000 target enrollmentApril 21, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
2000
Locations
1
Primary Endpoint
Clinical Data
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

Registry
clinicaltrials.gov
Start Date
April 21, 2024
End Date
May 2033
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Written informed consent was obtained to participate in the study and HIPAA
  • Authorization for release of personal health information. Ability to understand and willingness to sign informed consent
  • Diagnosed with or is suspected to have metastatic cancer.
  • Age ≥ 18 years at the time of consent.
  • Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.

Exclusion Criteria

  • All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:
  • Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.

Outcomes

Primary Outcomes

Clinical Data

Time Frame: Up to 1 month

Clinical data and radiological assessments from participants with metastatic cancer receiving radiation therapy as a part of the standard of care will be collected.

Secondary Outcomes

  • Patient reported outcomes (PRO)(Baseline, 1 month, 3 months, 6 months, 9 months, and 12 months)

Study Sites (1)

Loading locations...

Similar Trials